Distinct and sequential re-replication barriers ensure precise genome duplication.


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
08 2020
Historique:
received: 21 01 2020
accepted: 12 07 2020
revised: 04 09 2020
pubmed: 26 8 2020
medline: 24 9 2020
entrez: 26 8 2020
Statut: epublish

Résumé

Achieving complete and precise genome duplication requires that each genomic segment be replicated only once per cell division cycle. Protecting large eukaryotic genomes from re-replication requires an overlapping set of molecular mechanisms that prevent the first DNA replication step, the DNA loading of MCM helicase complexes to license replication origins, after S phase begins. Previous reports have defined many such origin licensing inhibition mechanisms, but the temporal relationships among them are not clear, particularly with respect to preventing re-replication in G2 and M phases. Using a combination of mutagenesis, biochemistry, and single cell analyses in human cells, we define a new mechanism that prevents re-replication through hyperphosphorylation of the essential MCM loading protein, Cdt1. We demonstrate that Cyclin A/CDK1 can hyperphosphorylate Cdt1 to inhibit MCM re-loading in G2 phase. The mechanism of inhibition is to block Cdt1 binding to MCM independently of other known Cdt1 inactivation mechanisms such as Cdt1 degradation during S phase or Geminin binding. Moreover, our findings suggest that Cdt1 dephosphorylation at the mitosis-to-G1 phase transition re-activates Cdt1. We propose that multiple distinct, non-redundant licensing inhibition mechanisms act in a series of sequential relays through each cell cycle phase to ensure precise genome duplication.

Identifiants

pubmed: 32841231
doi: 10.1371/journal.pgen.1008988
pii: PGENETICS-D-20-00103
pmc: PMC7473519
doi:

Substances chimiques

CDT1 protein, human 0
Cell Cycle Proteins 0
Cyclin A 0
Geminin 0
CDC2 Protein Kinase EC 2.7.11.22
Minichromosome Maintenance Proteins EC 3.6.4.12

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1008988

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM102413
Pays : United States
Organisme : NIGMS NIH HHS
ID : F31 GM121073
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nucleic Acids Res. 2015 Jan;43(Database issue):D512-20
pubmed: 25514926
Nat Cell Biol. 2010 Nov;12(11):1086-93
pubmed: 20953199
J Biol Chem. 2005 Jun 17;280(24):23416-23
pubmed: 15855168
Elife. 2019 Sep 27;8:
pubmed: 31560342
J Biol Chem. 2004 Jul 16;279(29):30807-16
pubmed: 15138268
Genes Dev. 2007 Mar 1;21(5):497-518
pubmed: 17344412
Genome Res. 2007 Dec;17(12):1797-808
pubmed: 17984227
Mol Cell Biol. 1996 Nov;16(11):6486-93
pubmed: 8887677
Cell Cycle. 2010 Dec 15;9(24):4848-57
pubmed: 21099365
EMBO J. 1992 Nov;11(11):3985-94
pubmed: 1327754
Nat Struct Mol Biol. 2017 Mar;24(3):309-315
pubmed: 28191892
J Biol Chem. 2004 May 7;279(19):19691-7
pubmed: 14993212
Curr Opin Cell Biol. 1991 Apr;3(2):176-84
pubmed: 1831990
J Biol Chem. 2015 Jan 2;290(1):556-67
pubmed: 25411249
Nat Rev Cancer. 2008 Oct;8(10):799-806
pubmed: 18756287
Nat Struct Mol Biol. 2017 Mar;24(3):316-324
pubmed: 28191893
Mol Biol Cell. 2018 Dec 1;29(25):2989-3002
pubmed: 30281379
Nat Cell Biol. 2004 Oct;6(10):1003-9
pubmed: 15448697
J Biol Chem. 2007 Aug 3;282(31):22984-92
pubmed: 17548358
Cell Rep. 2017 May 2;19(5):928-938
pubmed: 28467906
Nature. 2004 Aug 19;430(7002):913-7
pubmed: 15286659
Curr Opin Cell Biol. 2007 Dec;19(6):663-71
pubmed: 18053699
Trends Cell Biol. 2011 Aug;21(8):452-60
pubmed: 21632252
J Biol Chem. 2004 Mar 5;279(10):9625-33
pubmed: 14672932
Science. 2000 Dec 22;290(5500):2309-12
pubmed: 11125146
Nat Cell Biol. 2006 Jan;8(1):84-90
pubmed: 16362051
Cell Cycle. 2016 May 2;15(9):1213-26
pubmed: 26940553
Cell. 1998 Jun 12;93(6):1043-53
pubmed: 9635433
Mol Cell Proteomics. 2006 Apr;5(4):749-57
pubmed: 16340016
Nat Commun. 2013;4:2065
pubmed: 23817338
Genes (Basel). 2019 Jan 29;10(2):
pubmed: 30700044
Nat Commun. 2017 Jun 23;8:15720
pubmed: 28643783
Genes Dev. 2014 Feb 15;28(4):372-83
pubmed: 24532715
Mol Cell Biol. 2011 Nov;31(22):4405-16
pubmed: 21930785
Mol Cell Biol. 2009 Jun;29(12):3332-43
pubmed: 19364817
Nature. 2001 Jun 28;411(6841):1068-73
pubmed: 11429609
Crit Rev Biochem Mol Biol. 2017 Apr;52(2):107-144
pubmed: 28094588
Protein Cell. 2010 Mar;1(3):227-36
pubmed: 21203969
Mol Cell. 2003 Apr;11(4):997-1008
pubmed: 12718885
Genes (Basel). 2016 Dec 22;8(1):
pubmed: 28025526
Biochem Biophys Res Commun. 1989 Mar 31;159(3):871-7
pubmed: 2539153
Nucleic Acids Res. 2015 Dec 15;43(22):e150
pubmed: 26250117
Mol Cell Biol. 2006 Jun;26(12):4642-51
pubmed: 16738328
EMBO J. 2004 Aug 4;23(15):3122-32
pubmed: 15257290
Nucleic Acids Res. 2005 Jan 13;33(1):316-24
pubmed: 15653632
Cell. 2005 Sep 23;122(6):915-26
pubmed: 16153703
J Biol Chem. 2001 Nov 30;276(48):44905-11
pubmed: 11555648
Mol Cell. 2011 Oct 7;44(1):62-71
pubmed: 21856198
J Cell Biol. 2001 Apr 2;153(1):121-36
pubmed: 11285279
J Biol Chem. 2003 May 23;278(21):18817-23
pubmed: 12657641
Elife. 2017 Nov 17;6:
pubmed: 29148972
Protein Sci. 2009 Nov;18(11):2252-64
pubmed: 19722278
Curr Biol. 2014 May 19;24(10):R435-44
pubmed: 24845676
Methods Mol Biol. 2007;365:23-38
pubmed: 17200551
J Biol Chem. 2008 Mar 14;283(11):6817-25
pubmed: 18184650
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):
pubmed: 23838438
Trends Biochem Sci. 2010 Aug;35(8):450-8
pubmed: 20399103
J Cell Biol. 2004 May 24;165(4):473-82
pubmed: 15159417
Nat Cell Biol. 2012 May 13;14(6):593-603
pubmed: 22581055
Mol Cell Biol. 2004 Aug;24(16):7140-50
pubmed: 15282313
Nat Cell Biol. 2003 Nov;5(11):1008-15
pubmed: 14578910
Biochim Biophys Acta. 2010 Mar;1804(3):511-9
pubmed: 19822225
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10660-5
pubmed: 16818887
EMBO J. 2006 Mar 8;25(5):1126-36
pubmed: 16482215
Nat Struct Mol Biol. 2017 Mar;24(3):300-308
pubmed: 28191894
Oncogene. 2005 Nov 24;24(53):7941-5
pubmed: 16027723
Genes Dev. 2005 Jan 1;19(1):114-26
pubmed: 15598982
J Cell Biol. 2001 Apr 2;153(1):137-48
pubmed: 11285280
Carcinogenesis. 2008 Feb;29(2):237-43
pubmed: 18048387
Nature. 2011 Oct 12;480(7375):128-31
pubmed: 21993622
J Cell Biol. 2018 Oct 1;217(10):3446-3463
pubmed: 30154187
J Mol Cell Biol. 2011 Feb;3(1):13-22
pubmed: 21278447
J Biol Chem. 2002 Oct 25;277(43):40871-80
pubmed: 12192004
J Cell Sci. 2012 May 15;125(Pt 10):2436-45
pubmed: 22366459
Microbiol Mol Biol Rev. 2004 Jun;68(2):320-44
pubmed: 15187187
Science. 1997 Dec 12;278(5345):1957-60
pubmed: 9395400
Annu Rev Biochem. 2010;79:89-130
pubmed: 20373915
Neuroscience. 2002;112(3):583-91
pubmed: 12074900
Cell Rep. 2017 Mar 7;18(10):2508-2520
pubmed: 28273463
Nat Rev Mol Cell Biol. 2010 Oct;11(10):728-38
pubmed: 20861881
Int J Biol Sci. 2009;5(1):44-51
pubmed: 19159010
J Cell Biol. 2011 May 16;193(4):677-94
pubmed: 21576393
EMBO Rep. 2017 Mar;18(3):403-419
pubmed: 28077461

Auteurs

Yizhuo Zhou (Y)

Department of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United State of America.

Pedro N Pozo (PN)

Curriculum in Genetics and Molecular Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United State of America.

Seeun Oh (S)

F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute and the Research Division of Immunology, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United State of America.

Haley M Stone (HM)

Department of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United State of America.

Jeanette Gowen Cook (JG)

Department of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United State of America.
Curriculum in Genetics and Molecular Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United State of America.
Lineberger Comprehensive Cancer, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United State of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH